Skip to content

A Questionnaire Survey for Biliary Tract Cancers

A Questionnaire Survey Study for Establishment of Surveillance and Prevention Through the Analysis of Epidemiologic Risk Factors in Patients With Biliary Tract Cancers

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04731220
Enrollment
12000
Registered
2021-01-29
Start date
2020-07-14
Completion date
2025-12-31
Last updated
2021-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Tract Cancer

Brief summary

The purpose of this study is: * To evaluate risk factors for cancers of the biliary tract by registering new patients and their counterparts in a multi-center program * Development of programs by creating a multi-center biliary tract cancer registration system

Interventions

None listed

Sponsors

Kyungpook National University Hospital
CollaboratorOTHER
Pusan National University Hospital
CollaboratorOTHER
Pusan National University Yangsan Hospital
CollaboratorOTHER
Kyungpook National University Chilgok Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Study population : * Newly diagnosis of biliary tract cancers - Pathological or Radiological or other clinical diagnosis of biliary tract cancers * Informed consent * Control : * with no previous cancer diagnosis * Informed consent

Exclusion criteria

* Previous diagnosis of bile duct cancer with resection operation, endoscopic resection, chemotherapy or radiation therapy * Prior diagnosis of other cancer in 5 years or ongoing cancer treatment * Patients' refusal

Design outcomes

Primary

MeasureTime frameDescription
Number and percentage of cases and controls who complete each part of the study5 yearsInformation is obtained by a questionnaire, laboratory findings, image data, physiological parameter.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026